GLI1 and diffuse large B-cell lymphoma: For example, it was found that MYC-regulated NEAT1 promoted diffuse large B-cell lymphoma (DLBCL) proliferation via the miR-34b-5p-GLI1 pathway, which could provide a novel therapeutic target for DLBCL (Qian et al., 2020).